SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001389933-15-000011
Filing Date
2015-02-17
Accepted
2015-02-13 18:48:30
Documents
1
Group Members
NATHAN FISCHEL, FARIBA GHODSIAN

Document Format Files

Seq Description Document Type Size
1 dafna13gAVXL2014.txt SC 13G 10136
  Complete submission text file 0001389933-15-000011.txt   11795
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Subject) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-81767 | Film No.: 15617109
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 10990 WILSHIRE BOULEVARD SUITE 1400 LOS ANGELES CA 90024
Business Address 10990 WILSHIRE BOULEVARD SUITE 1400 LOS ANGELES CA 90024 (310) 954-3200
DAFNA Capital Management LLC (Filed by) CIK: 0001389933 (see all company filings)

IRS No.: 364334068
Type: SC 13G